News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
320 Results
Type
Article (8)
Company Profile (1)
Press Release (311)
Section
Business (60)
Deals (12)
Drug Development (103)
FDA (6)
Job Trends (3)
News (191)
Policy (27)
Tag
Alliances (15)
Antibody-drug conjugate (ADC) (1)
Approvals (5)
Best Places to Work (1)
Biotechnology (1)
Cancer (2)
Cell therapy (1)
Clinical research (90)
Collaboration (1)
C-suite (1)
Earnings (24)
Events (31)
Executive appointments (1)
FDA (7)
Funding (2)
Government (1)
Immunology and inflammation (1)
IPO (6)
Job creations (2)
JPM (1)
Legal (1)
Manufacturing (1)
Mergers & acquisitions (7)
NextGen: Class of 2026 (3)
People (23)
Phase 1 (7)
Phase 2 (49)
Phase 3 (37)
Pipeline (1)
Policy (1)
Postmarket research (3)
Preclinical (9)
Regulatory (28)
Series A (1)
Series B (1)
Special edition (1)
Startups (1)
The Weekly (1)
Vaccines (3)
Venture capital (1)
Date
Last 30 days (1)
Last 365 days (13)
2026 (2)
2025 (12)
2024 (7)
2023 (6)
2022 (3)
2021 (4)
2020 (9)
2019 (9)
2018 (7)
2017 (22)
2016 (18)
2015 (24)
2014 (24)
2013 (38)
2012 (35)
2011 (31)
2010 (27)
Location
Asia (11)
Australia (3)
California (2)
China (1)
Europe (26)
Massachusetts (4)
Nevada (1)
Pennsylvania (1)
South America (1)
Southern California (2)
United States (7)
320 Results for "delphia therapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Delphia Therapeutics Appoints Leading Cancer Expert Steve Kelsey, M.D., to Board of Directors
December 10, 2025
·
3 min read
Podcast
A Conversation With Kevin Marks, CEO of Delphia
In the second podcast in a special series focused on
BioSpace
’s NextGen Class of 2025, Senior Editor Annalee Armstrong speaks with Kevin Marks, CEO of Delphia Therapeutics.
March 4, 2025
·
1 min read
·
Annalee Armstrong
NextGen
Delphia Eyes New Precision Medicine Approach: Activation Lethality
Delphia launched in May 2024 with the goal of forcing malignant cells to overactivate and die.
March 4, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Delphia Therapeutics Appoints Reza Mazhari, Ph.D., as Chief Business Officer
May 28, 2025
·
2 min read
Genetown
Delphia Therapeutics Launches to Pioneer a New Field of Cancer Medicines: Activation Lethality
Delphia Therapeutics, Inc., announced its launch to pioneer a new area of cancer biology – activation lethality – which targets cancer’s surprising vulnerability to oncogene overactivation.
May 2, 2024
·
5 min read
Press Releases
Tubulis Adds Steve Kelsey as Independent Director to its Advisory Board
January 27, 2026
·
3 min read
Delphia Therapeutics
Press Releases
Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio
January 7, 2026
·
5 min read
Press Releases
aTyr Pharma Announces Findings from Interim Analysis of Ongoing Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)
June 4, 2025
·
7 min read
Regulatory
Biotech Leaders Implore Sen. Cassidy To Step Up in Wake of FDA Cuts
Biotech companies are already seeing regulatory delays and plenty of uncertainty after around 3,500 FDA employees were cut by the Trump administration.
April 10, 2025
·
3 min read
·
Annalee Armstrong
1 of 32
Next
